<DOC>
	<DOCNO>NCT00510172</DOCNO>
	<brief_summary>We hypothesise intravenous infusion PGI2 induce headache migraine cranial vasodilatation migraineurs .</brief_summary>
	<brief_title>Migraine Inducing Effects Changes Brain Haemodynamics PGI2</brief_title>
	<detailed_description />
	<mesh_term>Headache</mesh_term>
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Epoprostenol</mesh_term>
	<mesh_term>Tezosentan</mesh_term>
	<criteria>migraine without aura healthy apart age 1855 year 50100 kg Secure contraceptives Tension Type Headache 3 time month Other primary headache Medication prior study ( close 4 time plasma halflife ) Migraine headache 5 day prior study . Hypertension ( systolic BP &gt; 150 mmHg and/or diastolic BP &gt; 100 mmHg ) . Hypotension ( systolic BP &lt; 90 mmHg and/or diastolic BP &lt; 50 mmHg ) . Heartvessel disease kind incl cerebrovascular disease . Anamnestic clinical sign psychiatric disease abuse . Anamnestic clinical sign disease kind relevant participation study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2007</verification_date>
	<keyword>Headache</keyword>
	<keyword>Migraine</keyword>
	<keyword>Vasodilatation</keyword>
</DOC>